Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA) for its API manufacturing facility (CTO 5) in Miryalaguda, Telangana, India. The USFDA has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.